Valid Ghana · FDA Ghana

ACOTIN 10 CAPSULES (Each soft gel contains Isotrelinum 10 mg)

Isotrelinum

FDA/SD.265-020145 Isotrelinum 10mg

What it does

Isotrelinum is a topical medication used for treating certain skin conditions.

Commonly used for: acne, seborrheic dermatitis

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
FDA/SD.265-020145
Registration date
2026-02-12
Expiry date
2031-09-01
Status
Valid
Active ingredient
Isotrelinum
Dosage form
Isotrelinum
Strength
10mg
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Mega Life Sciences
Country of origin
INDIA
Manufacturer location
8 Dzorwulu Cres, Accra, Ghana

Source: Food and Drugs Authority · fetched 2026-05-22 02:34:45 · updated 2026-10-20 04:00:09

Disclaimer: This information is sourced from Food and Drugs Authority (Ghana). Always consult a qualified healthcare professional before using any medication.

About this medicine

Isotrelinum is a topical medication used for treating certain skin conditions.

What it treats

  • acne
  • seborrheic dermatitis

How it works

Isotrelinum helps to reduce skin oil production and promotes skin cell turnover, which can improve the appearance of the skin.

Who it's for

Isotrelinum is for people suffering from acne or related skin issues.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: isotrelinum

Isotrelinum, commonly known as isotretinoin, is a retinoid used primarily for the treatment of severe acne vulgaris that has not responded to other therapies. It works by reducing sebaceous gland activity, leading to decreased sebum production and a reduction in the formation of acne lesions. Isotretinoin has anti-inflammatory properties and promotes the normalization of follicular keratinization.

Indications

  • Severe acne vulgaris
  • Nodular acne
  • Acne conglobata
  • Acne fulminans

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on age and weight.

Adults: Refer to the relevant prescribing guidelines for specific dosing information based on individual patient circumstances.

Mechanism of action

Isotretinoin exerts its effects by binding to retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which are nuclear receptors that regulate gene expression. This binding leads to altered transcription of genes involved in cell growth, differentiation, and apoptosis. Isotretinoin decreases the size and activity of sebaceous glands, reduces sebum production, and promotes the turnover of epithelial cells in the hair follicles, preventing the clogging that leads to acne formation.

Pharmacodynamics

Isotretinoin has a profound effect on the skin and sebaceous glands. It reduces the size of sebaceous glands and the volume of sebum they produce, leading to a decrease in the number of acne lesions. The drug also exhibits anti-inflammatory effects, which help decrease the redness and swelling associated with acne. Furthermore, it alters keratinization, promoting normal skin cell turnover and preventing clogged pores.

Pharmacokinetics

Isotretinoin is well absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring 1-4 hours after oral administration. It is highly lipophilic and is extensively bound to plasma proteins. The drug undergoes hepatic metabolism, primarily via cytochrome P450 enzymes, and is converted to its active metabolites, including 4-oxo-isotretinoin. The elimination half-life of isotretinoin is approximately 10-20 hours, and it is primarily excreted in urine as metabolites.

Contra-indications

  • Hypersensitivity to isotretionin or any excipients
  • Pregnancy
  • Severe hepatic impairment
  • Hypervitaminosis A
  • Concurrent use of tetracyclines

Adverse effects

  • Dry skin
  • Chapped lips
  • Nosebleeds
  • Headaches
  • Muscle and joint pain
  • Increased liver enzymes
  • Elevated triglycerides
  • Mood changes
  • Visual disturbances

Interactions

  • Tetracyclines - increased risk of intracranial hypertension
  • Vitamin A supplements - risk of hypervitaminosis A
  • St. John's Wort - potential for reduced efficacy of isotretionin

Precautions

  • Regular monitoring of liver function tests and lipid levels
  • Use caution in patients with a history of mental health disorders
  • Avoid concurrent use of other retinoids
  • Patients should be advised to avoid sun exposure and use sunscreen

Pregnancy

Isotretionin is highly teratogenic. It is contraindicated in pregnancy due to the risk of severe birth defects.

Breast-feeding

Isotretionin is contraindicated during breastfeeding as it may be excreted in breast milk and could harm the nursing infant.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Capsules
  • Topical gel
  • Topical cream

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.